GRI INDEX

• Covered
• Partially Covered
• Not Covered

• Covered
• Partially Covered
• Not Covered

REPORT PROFILE

REPORT SCOPE AND BOUNDARY

GRI CONTENT INDEX

ASSURANCE

• Covered
• Partially Covered
• Not Covered

GOVERNANCE

COMMITMENTS TO EXTERNAL INITIATIVES

STAKEHOLDER ENGAGEMENT

• Covered
• Partially Covered
• Not Covered

ECONOMIC DISCLOSURES

The economic dimension of sustainability concerns the organization's impacts on the economic conditions of its stakeholders and on economic systems at local, national, and global levels. The Economic Indicators illustrate:

• Flow of capital among different stakeholders; and
• Main economic impacts of the organization throughout society.

Financial performance is fundamental to understanding an organization and its own sustainability. However, this information is normally already reported in financial accounts. What is often reported less, and is frequently desired by users of sustainability reports, is the organization's contribution to the sustainability of a larger economic system.

• DISCLOSURE ON MANAGEMENT APPROACH (ECONOMY)

  Provide a concise disclosure on the Management Approach items outlined below with reference to the following Economic Aspects:

  • Economic Performance;
  • Market Presence; and
  • Indirect Economic Impacts.

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Economic Aspects. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		From Our CEO
  	POLICYBrief, organization-wide policy (or policies) that defines the organization's overall commitment relating to the Economic Aspects listed above, or state where this can be found in the public domain (e.g., web link).		From Our CEO Financial Performance Global Opportunities Expanding Access to Health
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational risks and opportunities; Major changes in the reporting period to systems or structures to improve performance; and Key strategies for implementing policies or achieving performance.		From Our CEO Financial Performance Global Opportunities Expanding Access to Health

  • Covered
  • Partially Covered
  • Not Covered
• ECONOMIC PERFORMANCE INDICATORS

  ASPECT: ECONOMIC PERFORMANCE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EC1	Direct economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments.		Financial Performance
  EC2	Financial implications and other risks and opportunities for the organization's activities due to climate change.		Climate Change Position Statement		7,8
  EC3	Coverage of the organization's defined benefit plan obligations.
  EC4	Significant financial assistance received from government.

  ASPECT: MARKET PRESENCE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EC5	Range of ratios of standard entry level wage compared to local minimum wage at significant locations of operation.				6
  EC6	Policy, practices, and proportion of spending on locally-based suppliers at significant locations of operation.
  EC7	Procedures for local hiring and proportion of senior management hired from the local community at locations of significant operation.				6

  ASPECT: INDIRECT ECONOMIC IMPACTS

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EC8	Development and impact of infrastructure investments and services provided primarily for public benefit through commercial, in-kind, or pro bono engagement.		Expanding Access to Health
  EC9	Understanding and describing significant indirect economic impacts, including the extent of impacts.		Expanding Access to Health

  • Covered
  • Partially Covered
  • Not Covered

ENVIRONMENTAL DISCLOSURES

The environmental dimension of sustainability concerns an organization's impacts on living and non-living natural systems, including ecosystems, land, air, and water. Environmental Indicators cover performance related to inputs (e.g., material, energy, water) and outputs (e.g., emissions, effluents, waste). In addition, they cover performance related to biodiversity, environmental compliance, and other relevant information such as environmental expenditure and the impacts of products and services.

• DISCLOSURE ON MANAGEMENT APPROACH (ENVIRONMENT)

  Provide a concise disclosure on the Management Approach items outlined below with reference to the following Environmental Aspects:

  • Materials;
  • Energy;
  • Water;
  • Biodiversity;
  • Emissions, Effluents, and Waste;
  • Products and Services;
  • Compliance;
  • Transport; and
  • Overall

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Environmental Aspects. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		Protecting the Environment
  	POLICY Brief, organization-wide policy (or policies) that defines the organization's overall commitment related to the Environmental Aspects listed above or state where this can be found in the public domain (e.g., web link).		EHS Policy Statement
  	ORGANIZATIONAL RESPONSIBILITY The most senior position with operational responsibility for Environmental Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.		EHS Governance
  	TRAINING AND AWARENESS Procedures related to training and raising awareness in relation to the Environmental Aspects.		Supplier Review/a>
  	MONITORING AND FOLLOW-UP Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain. List of certifications for environment-related performance or certification systems, or other approaches to auditing/verification for the reporting organization or its supply chain.		Key Performance Indicators
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational risks and opportunities; Major changes in the reporting period to systems or structures to improve performance; and Key strategies and procedures for implementing policies or achieving goals.		Protecting the Environment

  • Covered
  • Partially Covered
  • Not Covered
• ENVIRONMENTAL PERFORMANCE INDICATORS

  ASPECT: MATERIALS

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN1	Materials used by weight or volume.				8
  EN2	Percentage of materials used that are recycled input materials.				8,9

  ASPECT: ENERGY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN3	Direct energy consumption by primary energy source.				8
  EN4	Indirect energy consumption by primary source.				8
  EN5	Energy saved due to conservation and efficiency improvements.				8,9
  EN6	Initiatives to provide energy-efficient or renewable energy based products and services, and reductions in energy requirements as a result of these initiatives.		Protecting the Environment		8,9
  EN7	Initiatives to reduce indirect energy consumption and reductions achieved.		Protecting the Environment		8,9

  ASPECT: WATER

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN8	Total water withdrawal by source.		EHS Performance Dashboard		8
  EN9	Water sources significantly affected by withdrawal of water.		EHS Performance Dashboard
  EN10	Percentage and total volume of water recycled and reused.		EHS Performance Dashboard		8

  ASPECT: BIODIVERSITY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN11	Location and size of land owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas.				8
  EN12	Description of significant impacts of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areas.				8
  EN13	Habitats protected or restored.				8
  EN14	Strategies, current actions, and future plans for managing impacts on biodiversity.				8
  EN15	Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk.				8

  ASPECT: EMISSIONS, EFFLUENTS, AND WASTE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN16	Total direct and indirect greenhouse gas emissions by weight.		Environment KPIs		8
  EN17	Other relevant indirect greenhouse gas emissions by weight.				8
  EN18	Initiatives to reduce greenhouse gas emissions and reductions achieved.		EHS Performance Dashboard		8,9
  EN19	Emissions of ozone-depleting substances by weight.				8
  EN20	NO, SO, and other significant air emissions by type and weight.				8
  EN21	Total water discharge by quality and destination.
  EN22	Total weight of waste by type and disposal method.		EHS Performance Dashboard		8
  EN23	Total number and volume of significant spills.				8
  EN24	Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally.		EHS Performance Dashboard		8
  EN25	Identity, size, protected status, and biodiversity value of water bodies and related habitats significantly affected by the reporting organization's discharges of water and runoff.				8

  ASPECT: PRODUCTS AND SERVICES

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN26	Initiatives to mitigate environmental impacts of products and services, and extent of impact mitigation.		Green Journey		8,9
  EN27	Percentage of products sold and their packaging materials that are reclaimed by category.				8,9

  ASPECT: COMPLIANCE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN28	Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations.		EHS Compliance		8

  ASPECT: TRANSPORT

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN29	Significant environmental impacts of transporting products and other goods and materials used for the organization's operations, and transporting members of the workforce.				8

  ASPECT: OVERALL

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  EN30	Total environmental protection expenditures and investments by type.				8

  • Covered
  • Partially Covered
  • Not Covered

SOCIAL DISCLOSURES

The social dimension of sustainability concerns the impacts an organization has on the social systems within which it operates. The GRI Social Performance Indicators identify key Performance Aspects surrounding labor practices, human rights, society, and product responsibility.

• LABOR PRACTICES AND DECENT WORK

  The specific Aspects under the category of Labor Practices are based on internationally recognized universal standards, including:

  • United Nations Universal Declaration of Human Rights and its Protocols;
  • United Nations Convention: International Covenant on Civil and Political Rights;
  • United Nations Convention: International Covenant on Economic, Social, and Cultural Rights;
  • ILO Declaration on Fundamental Principles and Rights at Work of 1998 (in particular the eight core conventions of the ILO); and
  • The Vienna Declaration and Programme of Action.
• DISCLOSURE ON MANAGEMENT APPROACH (LABOR PRACTICES AND DECENT WORK)

  Provide a concise disclosure on the following Management Approach items with reference to the Labor Aspects listed below. The ILO Tripartite Declaration Concerning Multinational Enterprises and Social Policy (in particular the eight core conventions of the ILO) and the Organisation for Economic Co-operation and Development Guidelines for Multinational Enterprises, should be the primary reference points.

  • Employment;
  • Labor/Management Relations;
  • Occupational Health and Safety;
  • Training and Education; and
  • Diversity and Equal Opportunity.

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Labor Aspects, indicating their linkage to the internationally recognized universal standards. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		Human Rights
  	POLICY Brief, organization-wide policy (or policies) that defines the organization's overall commitment related to the Labor Aspects, or state where this can be found in the public domain (e.g., web link). Also reference their linkage to the international standards indicated above.		Human Rights Compliance
  	ORGANIZATIONAL RESPONSIBILITY The most senior position with operational responsibility for Labor Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.
  	TRAINING AND AWARENESS Procedures related to training and raising awareness in relation to the Labor Aspects.		Compliance
  	MONITORING AND FOLLOW-UP Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain. List of certifications for labor-related performance or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.		PSCI and External Certifications EHS External Supply: Compliance
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational environmental risks and opportunities related to issues; Major changes in the reporting period to systems or structures to improve performance; and Key strategies and procedures for implementing policies or achieving goals		Human Rights

  • Covered
  • Partially Covered
  • Not Covered
• LABOR PRACTICES AND DECENT WORK PERFORMANCE INDICATORS

  ASPECT: EMPLOYMENT

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  LA1	Total workforce by employment type, employment contract, and region.
  LA2	Total number and rate of employee turnover by age group, gender, and region.				6
  LA3	Benefits provided to full-time employees that are not provided to temporary or part-time employees, by major operations.				6

  ASPECT: LABOR/MANAGEMENT RELATIONS

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  LA4	Percentage of employees covered by collective bargaining agreements.				1,3
  LA5	Minimum notice period(s) regarding operational changes, including whether it is specified in collective agreements.				3

  ASPECT: OCCUPATIONAL HEALTH AND SAFETY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  LA6	Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs.
  LA7	Rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities by region.		EHS Performance Dashboard
  LA8	Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases.
  LA9	Health and safety topics covered in formal agreements with trade unions.

  ASPECT: TRAINING AND EDUCATION

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  LA10	Average hours of training per year per employee by employee category.
  LA11	Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings.
  LA12	Percentage of employees receiving regular performance and career development reviews.

  ASPECT: DIVERSITY AND EQUAL OPPORTUNITY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  LA13	Composition of governance bodies and breakdown of employees per category according to gender, age group, minority group membership, and other indicators of diversity.				1,6
  LA14	Ratio of basic salary of men to women by employee category.				1,6

  • Covered
  • Partially Covered
  • Not Covered

• HUMAN RIGHTS

  Human Rights Performance Indicators require organizations to report on the extent to which human rights are considered in investment and supplier/contractor selection practices. Additionally, the Indicators cover employee and security forces training on human rights as well as non-discrimination, freedom of association, child labor, indigenous rights, and forced and compulsory labor.
  
  Generally recognized human rights are defined by the following Conventions and Declarations:

  • United Nations Universal Declaration of Human Rights and its Protocols;
  • United Nations Convention: International Covenant on Civil and Political Rights;
  • United Nations Convention: International Covenant on Economic, Social, and Cultural Rights;
  • ILO Declaration on Fundamental Principles and Rights at Work of 1998 (in particular the eight core conventions of the ILO); and
  • The Vienna Declaration and Programme of Action.
• DISCLOSURE ON MANAGEMENT APPROACH (HUMAN RIGHTS)

  Provide a concise disclosure on the following Management Approach items with reference to the Human Rights Aspects listed below. The ILO Tripartite Declaration Concerning Multinational Enterprises and Social Policy (in particular the eight core conventions of the ILO which consist of Conventions 100, 111, 87, 98, 138, 182, 20 and 1059), and the Organisation for Economic Cooperation and Development Guidelines for Multinational Enterprises should be the primary reference points.

  • Investment and Procurement Practices;
  • Non-discrimination;
  • Freedom of Association and Collective Bargaining;
  • Abolition of Child Labor;
  • Prevention of Forced and Compulsory Labor;
  • Complaints and Grievance Practices;
  • Security Practices; and
  • Indigenous Rights.

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Human Rights Aspects, indicating their linkage to the international declarations and standards listed above. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		Human Rights
  	POLICY Brief, organization-wide policy (or policies) that defines the organization's overall commitment to the Human Rights Aspects (including policies which may be reasonably considered likely to affect the decision of employees to join a trade union or bargain collectively), or state where this can be found in the public domain (e.g., web link). Also reference their linkage to the international declarations and standards indicated above.		Human Rights
  	ORGANIZATIONAL RESPONSIBILITY The most senior position with operational responsibility for Human Rights Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.
  	TRAINING AND AWARENESS Procedures related to training and raising awareness in relation to the Human Rights Aspects.
  	MONITORING AND FOLLOW-UP Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain. List of certifications for human rights-related performance, or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.		PSCI and External Certifications EHS External Supply Corporate Compliance
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational risks and opportunities; Major changes in the reporting period to systems or structures to improve performance; and Key strategies and procedures for implementing policies or achieving goals.		Human Rights

  • Covered
  • Partially Covered
  • Not Covered
• HUMAN RIGHTS PERFORMANCE INDICATORS

  ASPECT: INVESTMENT AND PROCUREMENT PRACTICES

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR1	Percentage and total number of significant investment agreements that include human rights clauses or that have undergone human rights screening.				1, 2, 3, 4, 5, 6
  HR2	Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken.				1, 2, 3, 4, 5, 6
  HR3	Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained.				1, 4, 5, 6

  ASPECT: NON-DISCRIMINATION

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR4	Total number of incidents of discrimination and actions taken.				1, 6

  ASPECT: FREEDOM OF ASSOCIATION AND COLLECTIVE BARGAINING

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR5	Operations identified in which the right to exercise freedom of association and collective bargaining may be at significant risk, and actions taken to support these rights.				1, 3

  ASPECT: CHILD LABOR

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR6	Operations identified as having significant risk for incidents of child labor, and measures taken to contribute to the elimination of child labor.				1, 5

  ASPECT: FORCED AND COMPULSORY LABOR

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR7	Operations identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of forced or compulsory labor.				1,4

  ASPECT: SECURITY PRACTICES

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR8	Percentage of security personnel trained in the organization's policies or procedures concerning aspects of human rights that are relevant to operations.				1,2

  ASPECT: INDIGENOUS RIGHTS

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  HR9	Total number of incidents of violations involving rights of indigenous people and actions taken.				1

  • Covered
  • Partially Covered
  • Not Covered

• SOCIETY

  Society Performance Indicators focus attention on the impacts organizations have on the communities in which they operate, and disclosing how the risks that may arise from interactions with other social institutions are managed and mediated. In particular, information is sought on the risks associated with bribery and corruption, undue impudence in public policy-making, and monopoly practices.

• DISCLOSURE ON MANAGEMENT APPROACH (SOCIETY)

  Provide a concise disclosure on the following Management Approach items with reference to the Society Aspects:

  • Community;
  • Corruption;
  • Public Policy;
  • Anti-Competitive Behavior; and
  • Compliance.

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Aspects indicated above. Use organization-specific Indicators as needed in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		Compliance
  	POLICY Brief, organization-wide policy (or policies) that defines the organization's overall commitment relating to the Society Aspects or state where this can be found in the public domain (e.g., web link).		Compliance
  	ORGANIZATIONAL RESPONSIBILITY The most senior position with operational responsibility for Society Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.		Compliance
  	TRAINING AND AWARENESS Procedures related to training and raising awareness in relation to the Society Aspects.
  	MONITORING AND FOLLOW-UP Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain. List of certifications for performance or certifications systems, or other approaches to auditing/verifying the reporting organization or its supply chain.		PSCI and External Certifications EHS External Supply Compliance
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational risks and opportunities; Major changes in the reporting period to systems or structures to improve performance; and Key strategies for implementing policies or achieving performance.		Compliance

  • Covered
  • Partially Covered
  • Not Covered
• SOCIETY PERFORMANCE INDICATORS

  ASPECT: COMMUNITY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  SO1	Nature, scope, and effectiveness of any programs and practices that assess and manage the impacts of operations on communities, including entering, operating, and exiting.				1

  ASPECT: CORRUPTION

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  SO2	Percentage and total number of business units analyzed for risks related to corruption.				10
  SO3	Percentage of employees trained in organization's anti-corruption policies and procedures.				10
  SO4	Actions taken in response to incidents of corruption.				10

  ASPECT: PUBLIC POLICY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  SO5	Public policy positions and participation in public policy development and lobbying.		Compliance		10
  SO6	Total value of financial and in-kind contributions to political parties, politicians, and related institutions by country.		Compliance		10

  ASPECT: ANTI-COMPETITIVE BEHAVIOR

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  SO7	Total number of legal actions for anti-competitive behavior, anti-trust, and monopoly practices and their outcomes.

  ASPECT: COMPLIANCE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  SO8	Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulations.

  • Covered
  • Partially Covered
  • Not Covered

• Product Responsibility

  Product Responsibility Performance Indicators address the aspects of a reporting organization's products and services that directly abet customers, namely, health and safety, information and labeling, marketing, and privacy.
  
  These aspects are chiefly covered through disclosure on internal procedures and the extent to which these procedures are not complied with.

• DISCLOSURE ON MANAGEMENT APPROACH (PRODUCT RESPONSIBILITY)

  Provide a concise disclosure on the following Management Approach items with reference to the Product Responsibility Aspects:

  • Customer Health and Safety;
  • Product and Service Labeling;
  • Marketing Communications;
  • Customer Privacy; and
  • Compliance.

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  	GOALS AND PERFORMANCE Organization-wide goals regarding performance relevant to the Product Responsibility Aspects. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.		Patient Safety Research & Development Sales and Marketing Compliance
  	POLICY Brief, organization-wide policy (or policies) that defines the organization's overall commitment to the Product Responsibility Aspects, or state where this can be found in the public domain (e.g., web link).		Patient Safety Research & Development Sales and Marketing Compliance
  	ORGANIZATIONAL RESPONSIBILITY The most senior position with operational responsibility for Product Responsibility Aspects, or explain how operational responsibility is divided at the senior level for Product Responsibility Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.
  	TRAINING AND AWARENESS Procedures related to training and raising awareness in relation to the Product Responsibility Aspects.
  	MONITORING AND FOLLOW-UP Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain. List of certifications for product responsibility-related performance or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.		Compliance
  	ADDITIONAL CONTEXTUAL INFORMATION Additional relevant information required to understand organizational performance, such as: Key successes and shortcomings; Major organizational risks and opportunities; Major changes in the reporting period to systems or structures to improve performance; and Key strategies for implementing policies or achieving performance.		Patient Safety Research & Development Sales and Marketing Compliance

  • Covered
  • Partially Covered
  • Not Covered
• PRODUCT RESPONSIBILITY PERFORMANCE INDICATORS

  ASPECT: CUSTOMER HEALTH AND SAFETY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  PR1	Life cycle stages in which health and safety impacts of products and services are assessed for improvement, and percentage of significant products and services categories subject to such procedures.		Patient Safety Research & Development Greener Process
  PR2	Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes.

  ASPECT: PRODUCT AND SERVICE LABELING

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  PR3	Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirements.		Product Labeling
  PR4	Total number of incidents of non-compliance with regulations and voluntary codes concerning product and service information and labeling, by type of outcomes.
  PR5	Practices related to customer satisfaction, including results of surveys measuring customer satisfaction.

  ASPECT: MARKETING COMMUNICATIONS

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  PR6	Programs for adherence to laws, standards, and voluntary codes related to marketing communications, including advertising, promotion, and sponsorship.		Compliance		10
  PR7	Total number of incidents of non-compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes.

  ASPECT: CUSTOMER PRIVACY

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  PR8	Total number of substantiated complaints regarding breaches of customer privacy and losses of customer data.

  ASPECT: COMPLIANCE

  GRI Guideline			Corresponding Pfizer Material		UNGC Principle
  PR9	Monetary value of significant fines for non-compliance with laws and regulations concerning the provision and use of products and services.

  • Covered
  • Partially Covered
  • Not Covered